Pakpoom Kheolamai
- Genetics top 5%
- Mesenchymal stem cell research 28
- Biomaterials top 10%
-
- MicroRNA in disease regulation 10
- Urology top 10%
-
- Pluripotent Stem Cells Research 13
- CRISPR and Genetic Engineering 6
- Angiogenesis and VEGF in Cancer 5
-
- Tissue Engineering and Regenerative Medicine 15
-
- Hippo pathway signaling and YAP/TAZ 8
-
- Bone Tissue Engineering Materials 6
- Co-authors
- Sirikul ManochantrChairat TantrawatpanSurapol IssaragrisilSarute UmmartyotinYaowalak U‐pratyaDuangrat TantikanlayapornAungkura SupokawejMethichit Wattanapanitch
- Cited by
- GeneticsBiomaterialsCancer Research
- Journals
- Stem Cell Research & Therapy (10 papers)Scientific Reports (8 papers)Annals of Hematology (4 papers)
- Partner nations
- ThailandUnited KingdomCanada
In The Last Decade
Pakpoom Kheolamai
58 papers receiving 982 citations
Peers
Comparison fields: 5 of 97
- Genetics 338
- Biomaterials 154
- Cancer Research 113
- Urology 43
- Molecular Biology 410
Countries citing papers authored by Pakpoom Kheolamai
This map shows the geographic impact of Pakpoom Kheolamai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pakpoom Kheolamai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pakpoom Kheolamai more than expected).
Fields of papers citing papers by Pakpoom Kheolamai
This network shows the impact of papers produced by Pakpoom Kheolamai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pakpoom Kheolamai. The network helps show where Pakpoom Kheolamai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pakpoom Kheolamai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 6 | |
| 10 | 2022 | 6 | |
| 11 | 2020 | 2 | |
| 12 | 2018 | 1 | |
| 13 | 2018 | 3 | |
| 14 | 2016 | 26 | |
| 15 | 2016 | 8 | |
| 16 | 2016 | 11 | |
| 17 | 2016 | 24 | |
| 18 | 2015 | 29 | |
| 19 | 2014 | 40 | |
| 20 | 2011 | 4 |
About Pakpoom Kheolamai
Pakpoom Kheolamai is a scholar working on Genetics, Cancer Research and Cell Biology, having authored 61 papers that have together received 992 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (28 papers), Tissue Engineering and Regenerative Medicine (15 papers), Pluripotent Stem Cells Research (13 papers), MicroRNA in disease regulation (10 papers), Hippo pathway signaling and YAP/TAZ (8 papers), CRISPR and Genetic Engineering (6 papers), Bone Tissue Engineering Materials (6 papers) and Angiogenesis and VEGF in Cancer (5 papers). The work is most often cited by research in Genetics (338 citations), Biomaterials (154 citations) and Cancer Research (113 citations). Pakpoom Kheolamai has collaborated with scholars based in Thailand, United Kingdom and Canada. Frequent co-authors include Sirikul Manochantr, Chairat Tantrawatpan, Surapol Issaragrisil, Sarute Ummartyotin, Yaowalak U‐pratya, Duangrat Tantikanlayaporn, Aungkura Supokawej, Methichit Wattanapanitch, Nuttha Klincumhom and Chuti Laowtammathron. Their work appears in journals such as Stem Cell Research & Therapy, Scientific Reports, Annals of Hematology, Stem Cell Research and Bioscience Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.